Literature DB >> 20694684

X-ray crystallography in drug discovery.

Ana Luísa Carvalho1, José Trincão, Maria João Romão.   

Abstract

Macromolecular X-ray crystallography is an important and powerful technique in drug discovery, used by pharmaceutical companies in the discovery process of new medicines. The detailed analysis of crystal structures of protein-ligand complexes allows the study of the specific interactions of a particular drug with its protein target at the atomic level. It is used to design and improve drugs. The starting point of these studies is the preparation of suitable crystals of complexes with potential ligands, which can be achieved by using different strategies described in this chapter. In addition, an introduction to X-ray crystallography is given, highlighting the fundamental steps necessary to determine the three-dimensional structure of protein-ligand complexes, as well as some of the tools and criteria to validate crystal structures available in databases.

Mesh:

Substances:

Year:  2009        PMID: 20694684     DOI: 10.1007/978-1-60761-244-5_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Models of protein-ligand crystal structures: trust, but verify.

Authors:  Marc C Deller; Bernhard Rupp
Journal:  J Comput Aided Mol Des       Date:  2015-02-10       Impact factor: 3.686

Review 2.  Structural insights into adrenergic receptor function and pharmacology.

Authors:  Brian K Kobilka
Journal:  Trends Pharmacol Sci       Date:  2011-03-15       Impact factor: 14.819

3.  Quantification of the effects of ionic strength, viscosity, and hydrophobicity on protein-ligand binding affinity.

Authors:  Christos P Papaneophytou; Asterios I Grigoroudis; Campbell McInnes; George Kontopidis
Journal:  ACS Med Chem Lett       Date:  2014-07-09       Impact factor: 4.345

4.  X-ray crystallography: Assessment and validation of protein-small molecule complexes for drug discovery.

Authors:  David R Cooper; Przemyslaw J Porebski; Maksymilian Chruszcz; Wladek Minor
Journal:  Expert Opin Drug Discov       Date:  2011-08-01       Impact factor: 6.098

5.  Methyl probes in proteins for determining ligand binding mode in weak protein-ligand complexes.

Authors:  Biswaranjan Mohanty; Julien Orts; Geqing Wang; Stefan Nebl; Wesam S Alwan; Bradley C Doak; Martin L Williams; Begoña Heras; Mehdi Mobli; Martin J Scanlon
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

6.  Mapping a protein recognition centre with chiral photoactive ligands. An integrated approach combining photophysics, reactivity, proteomics and molecular dynamics simulation studies.

Authors:  Daniel Limones-Herrero; Raúl Pérez-Ruiz; Emilio Lence; Concepción González-Bello; Miguel A Miranda; M Consuelo Jiménez
Journal:  Chem Sci       Date:  2017-01-05       Impact factor: 9.825

7.  The XChemExplorer graphical workflow tool for routine or large-scale protein-ligand structure determination.

Authors:  Tobias Krojer; Romain Talon; Nicholas Pearce; Patrick Collins; Alice Douangamath; Jose Brandao-Neto; Alexandre Dias; Brian Marsden; Frank von Delft
Journal:  Acta Crystallogr D Struct Biol       Date:  2017-02-24       Impact factor: 7.652

8.  Characterisation of Conformational and Ligand Binding Properties of Membrane Proteins Using Synchrotron Radiation Circular Dichroism (SRCD).

Authors:  Rohanah Hussain; Giuliano Siligardi
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

9.  Expression, purification and molecular analysis of the human ZNF706 protein.

Authors:  Jucimara Colombo; Paola Jocelan Scarin Provazzi; Marilia Freitas Calmon; Lilian Campos Pires; Nathália Campos Rodrigues; Paulo Petl; Marcelo Andrés Fossey; Fátima Pereira de Souza; Fernanda Canduri; Paula Rahal
Journal:  Biol Proced Online       Date:  2013-09-23       Impact factor: 3.244

10.  In Situ Proteolysis Condition-Induced Crystallization of the XcpVWX Complex in Different Lattices.

Authors:  Yichen Zhang; Shu Wang; Zongchao Jia
Journal:  Int J Mol Sci       Date:  2020-01-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.